市場調查報告書
商品編碼
1119129
動物生物技術全球市場規模調查,按產品類型,按應用,按動物類型,按最終用途,按地區預測 2022-2028Global Animal Biotechnology Market Size study, segmented by Product Type by Application Animal Type by End-Use and Regional Forecasts 2022-2028 |
2021 年全球動物生物技術市場價值約為 226.6 億美元,預計在 2022-2028 年的預測期內以超過 9.2% 的健康增長率增長。我來了。
動物生物技術是利用科學技術開發適用於製藥、工業和農業應用的基因。各種動物疾病呈上升趨勢,公共和私營公司對研究和開發活動的大量投資,以及政府促進動物健康的舉措和運動。根據獸醫癌症協會的數據,四分之一的狗最終會患上癌症,近 50% 的 10 歲以上的狗會患上癌症,”皮尤食品和生物技術倡議組織在 2018 年進行的一項研究。58% 的人反對涉及動物基因操作的科學研究。根據 2020 年 12 月發表在生物工程和生物技術前沿的一項題為“納米疫苗在牛疾病預防中的應用”的研究,疫苗是預防和控制牛傳染病的最有效策略之一。一。基於納米粒子的疫苗平台(納米疫苗)最近作為更傳統疫苗平台的可行替代品而廣受歡迎。因此,廣泛使用疫苗預防和控制動物疾病有望推動市場增長。此外,由於人類消費食品的營養價值提高,更豐富、更便宜和更多樣化的食品供應,保護農業用地,以及食品供應所需的動物減少,全球動物生物技術市場將在預測期內增長。它可能會增加市場增長。然而,轉基因或克隆動物生產的食品對人類健康造成危害的可能性尚不清楚。
全球動物生物技術市場研究中考慮的關鍵區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。北美正面臨越來越多的寵物飼養、人畜共患病和傳染病等動物疾病的流行、動物健康支出的增加、獸醫數量的增加以及用於藥物開發的獸醫數量的增加。有大量的醫院和由於大量的動物生物技術研究和開發活動,主導全球動物生物技術市場的診所。憑藉大量畜產品,亞太地區也是增長最快的市場,動物福利意識的增強和政府舉措有望推動市場增長。
本報告中包括的主要市場參與者是:
拜耳
生物成因
勃林格殷格翰有限公司
Ivaoes 有限責任公司
默克公司
輝瑞公司
賽諾菲
聖克魯斯生物技術
比爾巴克
碩騰公司
本研究的目的是確定近年來各個細分市場和國家/地區的市場規模,並預測未來 8 年的價值。該報告旨在捕捉所研究的每個地區和國家的行業的定性和定量方面。此外,它還提供了有關關鍵方面的詳細信息,例如定義市場未來增長的驅動因素和挑戰。此外,報告還應詳細分析主要參與者的競爭格局和產品供應,以及微觀市場中可供利益相關者投資的機會。市場的詳細細分和子細分如下所述。
按產品類型。
診斷測試
疫苗
藥品
生殖/遺傳學
飼料添加劑
按應用程序
動物疾病診斷
動物疾病的治療
動物預防醫學
藥物開發
按動物類型
伴侶
牲畜
按最終用戶
實驗室
護理點測試/內部測試
獸醫診所
雜項
按地區
北美
美國
加拿大
歐洲
英國
德國
法國
西班牙
意大利
其他歐洲
亞太地區
中國
印度
日本
澳大利亞
韓國
其他亞太地區
拉丁美洲
巴西
墨西哥
世界其他地方
此外,本研究考慮的年份是:
實際年份 - 2018 年、2019 年、2020 年
2021 年基準年
預測期 - 2022 年 至 2028 年
本報告的目標受眾是全球動物生物技術市場。
主要諮詢公司和顧問
大公司、中型公司、中小企業
風險投資
增值經銷商 (VAR)
第三方知識提供者
投資銀行家
投資者
Global Animal Biotechnology Market is valued approximately USD 22.66 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 9.2 % over the forecast period 2022-2028. Animal Biotechnology is the use of Science and Technology for developing genetically which are appropriate for pharmaceutical, industrial or agricultural applications. Increment in various animal diseases, large investment in research and development activities from both public and private firms, an increasing number of initiatives and campaigns are implemented by the government to promote animal health. According to Veterinary Cancer Society, 1 in 4 dogs will suffer from cancer at some point, and almost 50% of dogs over age 10 will develop cancer, According to a survey conducted by the Pew Initiative on Food and Biotechnology in 2018, 58 percent people opposed scientific research on the genetic engineering of animals. According to the study published in Frontiers in Bio-engineering and Biotechnology, titled 'Applications of Nanovaccines for Disease Prevention in Cattle' in December 2020, vaccines are one of the most effective strategies for preventing and controlling infectious illnesses in cattle. Nanoparticle-based vaccine platforms (nano vaccines) have recently gained traction as viable alternatives to more traditional vaccine platforms. The wide use of vaccines to prevent and control animal diseases is therefore expected to drive market growth. Also, enhanced nutritional content of food for human consumption, a more abundant, cheaper and varied food supply, agricultural land-use savings, a decrease in the number of animals needed for the food supply, the global Animal Biotechnology market is likely to increase the market growth during the forecast period. However, the unknown potential health effects to humans from food products created by transgenic or cloned animals
The key regions considered for the global Animal Biotechnology Market study includes Asia Pacific, North America, Europe, Latin America and Rest of the World. North America dominates the global animal biotechnology market due to rising pet adoption rates, increasing prevalence of animal diseases such as zoonotic and infectious, increasing expenditure on animal health, growing pool of veterinarians, large number of research and development activities for pharmaceutical development large number of hospitals and clinics. Also, Asia Pacific is the fastest growing market due to large livestock animal pool, increasing awareness of animal welfare and introduction of government initiatives are expected to contribute positively to the market's growth.
Major market player included in this report are:
Bayer AG
Biogenesis Bago
Boehringer Ingelheim GmbH
Ivaoes, LLC
Merck and Co. Inc
Pfizer Inc
Sanofi
Santa Cruz Biotechnology, Inc.
Virbac
Zoetis Inc
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Diagnostics Tests
Vaccines
Drugs
Reproductive and Genetic
Feed Additives
By Application:
Diagnosis of Animal Diseases
Treatment of Animal Diseases
Preventive Care of Animals
Drug Development
By Animal Type:
Companion
Livestock
By End-Use:
Laboratories
Point-of-Care Testing/In-house Testing
Veterinary Hospitals & Clinics
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
Rest of the World
Furthermore, years considered for the study are as follows:
Historical year - 2018, 2019, 2020
Base year - 2021
Forecast period - 2022 to 2028
Target Audience of the global Animal Biotechnology Market in Market Study:
Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers
Investors
List of figures